Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Resverlogix Corp T.RVX

Alternate Symbol(s):  RVXCF

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.


TSX:RVX - Post by User

Comment by narmacon Nov 19, 2020 1:15pm
127 Views
Post# 31933750

RE:RE:RE:exactly 1 yr ago...

RE:RE:RE:exactly 1 yr ago...,,,and,,,,all good stuff,,,,agreed,,and such as becoming a major pharma within 3 years,,etc,,etc,,etc,,,,,,,,,but the investing world does not believe DMcC,,,,,I do,,,but I am no biotech investing guru,,,,,just a retail player listening to what is presented to us minions by management,,,,,,,,,,,,the big players are staying clear,,,,,,,and have been doing so for the full year past even with these points you note whichadd to the derisking of this investment,,,,,,,its just plain odd,,very odd,,,,!

<< Previous
Bullboard Posts
Next >>